Class IIReported 2026-01-14

Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1

Recalled by Imprimis NJOF, LLC

Reason for Recall

Presence of particulate matter - Glass like particles.

Recall Number

D-0249-2026

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-12-18

Reported

2026-01-14

Distribution

U.S Nationwide

Code Info

Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.